Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADIANT: Radioembolization With Intra-arterial Angiotensin II
NCT07312292Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- May 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Angiotensin II in liver cancer. Started Jan 2026; status: recruiting.
02
Drugs
Angiotensin II
03
Conditions
liver cancer
Beyond the preview
Go deeper on NCT07312292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07312292.